MIR vs. CLBT, INTR, NABL, FA, WNS, PAY, RAMP, EVTC, LSPD, and HNI
Should you be buying Mirion Technologies stock or one of its competitors? The main competitors of Mirion Technologies include Cellebrite DI (CLBT), Inter & Co, Inc. (INTR), N-able (NABL), First Advantage (FA), WNS (WNS), Paymentus (PAY), LiveRamp (RAMP), EVERTEC (EVTC), Lightspeed Commerce (LSPD), and HNI (HNI). These companies are all part of the "business services" sector.
Cellebrite DI (NASDAQ:CLBT) and Mirion Technologies (NYSE:MIR) are both mid-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.
In the previous week, Cellebrite DI had 1 more articles in the media than Mirion Technologies. MarketBeat recorded 4 mentions for Cellebrite DI and 3 mentions for Mirion Technologies. Cellebrite DI's average media sentiment score of 1.75 beat Mirion Technologies' score of 0.73 indicating that Mirion Technologies is being referred to more favorably in the news media.
Cellebrite DI presently has a consensus price target of $12.42, suggesting a potential upside of 7.69%. Mirion Technologies has a consensus price target of $14.00, suggesting a potential upside of 35.92%. Given Cellebrite DI's higher probable upside, analysts clearly believe Mirion Technologies is more favorable than Cellebrite DI.
Mirion Technologies has a net margin of -9.87% compared to Mirion Technologies' net margin of -24.94%. Mirion Technologies' return on equity of 173.14% beat Cellebrite DI's return on equity.
Cellebrite DI received 17 more outperform votes than Mirion Technologies when rated by MarketBeat users. However, 72.73% of users gave Mirion Technologies an outperform vote while only 53.19% of users gave Cellebrite DI an outperform vote.
45.9% of Cellebrite DI shares are held by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are held by institutional investors. 5.7% of Cellebrite DI shares are held by company insiders. Comparatively, 2.2% of Mirion Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Cellebrite DI has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, Mirion Technologies has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.
Cellebrite DI has higher earnings, but lower revenue than Mirion Technologies. Cellebrite DI is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
Cellebrite DI beats Mirion Technologies on 9 of the 17 factors compared between the two stocks.
Get Mirion Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for MIR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mirion Technologies Competitors List
Related Companies and Tools
